Mar 17 |
Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
|
Mar 16 |
Pharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)
|
Mar 15 |
Pharming reports Q4 results
|
Mar 14 |
Earnings Scheduled For March 14, 2024
|
Feb 29 |
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
|
Feb 8 |
Pharming Group to participate in February investor conferences
|
Jan 8 |
Pharming Group issues full-year 2023 guidance
|
Jan 8 |
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
|
Nov 7 |
Pharming Group announces presentations at International Primary Immunodeficiencies Congress and the American College of Allergy, Asthma & Immunology Annual Scientific Meeting
|
Oct 27 |
Pharming Group N.V. (PHAR) Q3 2023 Earnings Call Transcript
|